相关实验视频

Updated: Jan 10, 2026

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

[什么是成年人不分化的全身性自身炎症性疾病? [2025年知识的现状]

Philippe Mertz¹, Jeanne Chauffier², Marion Delplanque²

¹Department of Internal Medicine, DMU3ID, Tenon Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris, 75020 Paris, France; French National Reference Center for Autoinflammatory Diseases (CEREMAIA), Paris, France; ERN RITA European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network, Utrecht, Netherlands; Pediatric Department, Versailles Hospital, Le Chesnay, France; Fédération hospitalo-universitaire INFLAMME, Paris, France; Inserm, CNRS, institut Cochin, université Paris-Cité, Paris, France.

La Revue de medecine interne

|November 21, 2025

概括

不分化的全身性自身炎症性疾病 (USAID) 影响了许多缺乏明确诊断的患者. 承认美国国际开发署对于及时管理和减少先天免疫障碍的诊断延迟至关重要.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
遗传学是一个遗传学.

背景情况:

系统性自身炎症性疾病 (SAID) 涉及天生的免疫失调,导致反复的炎症.
已知的形式包括单一性疾病 (例如,FMF,冷 Pyrinopathies) 和多因素性疾病 (例如,斯蒂尔病).
相当多的患者群体表现出自发炎性表型,没有确定的遗传变异或确定的诊断,称为无差异的全身自发炎性疾病 (USAID).

研究的目的:

在成年人中定义和表征不分化的全身性自身炎症性疾病 (USAID).
突出美国国际开发署的诊断挑战和新兴性质.
强调美国国际开发署对适当的患者管理的认可的重要性.

主要方法:

诊断依赖于持续的炎症综合征,六个月的症状进展,以及排除其他疾病.
调查包括连续生物测试,免疫查,自身抗体测试和遗传分析.
对先天免疫治疗 (例如,胆固醇,细胞因子抑制剂) 的治疗反应可以帮助诊断.

主要成果:

美国国际开发署提出了各种症状,如发烧,疲劳,关节痛和器官干扰,导致诊断延迟.
诊断需要排除感染,癌症,血液学和自身免疫性疾病.
对向治疗的治疗反应可以在模糊的情况下确认诊断.

结论:

美国国际开发署 (USAID) 在成年人中代表着一个重要的临床实体,弥合了单一性和多因素的SAID.
美国国际开发署 (USAID) 的早期识别对于尽量减少诊断不确定性和优化治疗策略至关重要.
需要对美国国际开发署进行进一步的研究,以完善诊断标准和治疗方法.

关键词:

这是一种自燃性炎症.自燃性炎症是一种自燃性炎症.自燃性炎症性疾病自燃性炎症性疾病疾病是自发炎性的疾病.

更多相关视频

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

相关概念视频

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...